Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.

about

Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q52643813

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@en

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@nl

type

Item

label

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@en

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@nl

prefLabel

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@en

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@nl

P1476

Role of RPLND and Metastasecto ...... tastatic Renal Cell Carcinoma.

@en

P2093

H Nagaraja

http://www.w3.org/2001/XMLSchema#string

N Srivatsa

http://www.w3.org/2001/XMLSchema#string

S Hemalatha

http://www.w3.org/2001/XMLSchema#string

S K Raghunath

http://www.w3.org/2001/XMLSchema#string

S Shweta

http://www.w3.org/2001/XMLSchema#string

P2860

The distribution of secondary growths in cancer of the breast. 1889

Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.

Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy

Renal-cell carcinoma.

The skeletal metastatic complications of renal cell carcinoma.

Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

Surgical treatment of renal cell cancer liver metastases: a population-based study.

Clinical outcome of patients with pancreatic metastases from renal cell cancer

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases.

P2888

s13193-018-0722-1

P304

105-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13193-018-0722-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29563747

http://www.w3.org/2001/XMLSchema#string

P932

5856704

http://www.w3.org/2001/XMLSchema#string